Post by Biogen
1,300,750 followers
Today, together with Eisai, we announced that the U.S. Food and Drug Administration (FDA) has approved a new delivery option for people living with early Alzheimer’s disease. This milestone reflects our commitment to addressing the evolving needs of the Alzheimer’s disease community. Learn more: https://lnkd.in/eXHqiHzz #News
Video Content